28 May 2021: OIA response | Country of manufacture for all funded medicines

28 May 2021

Dear [name and contact details withheld]

REQUEST FOR INFORMATION

Thank you for your request dated 6 May 2021 under the Official Information Act 1982 (OIA) for information relating to manufacturing medicines. You requested:

The country of manufacture for all funded pharmaceuticals by Pharmac.

Please note, we do not hold the information requested, therefore we are declining your request on the basis that the information is not held by PHARMAC (section 18(g)(i) of the OIA).

However, this information is included in the medicines data sheets held by Medsafe. An Excel (xlsx) version of the Pharmaceutical Schedule(external link) can be accessed via our website and cross referenced with the Medsafe database(external link) to identify the country of manufacture for all funded medicines.

I am informed that it can be difficult to cross-reference the two data sets as suppliers often use multiple sites/countries throughout the production process (for example, manufacturing, packing, labelling, testing, etc). You may need to speak directly with the supplier to confirm the precise details required. 

We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.

Yours sincerely

Rachel Read
Manager, Policy and Government Services